Noevir Holdings Co Ltd (4928)

Currency in JPY
4,740.0
+5.0(+0.11%)
Closed·
4928 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
High dividend Yield
4928 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4,705.04,760.0
52 wk Range
3,885.05,730.0
Key Statistics
Bid/Ask
4,730.00 / 4,745.00
Prev. Close
4,735
Open
4,740
Day's Range
4,705-4,760
52 wk Range
3,885-5,730
Volume
91.4K
Average Volume (3m)
54.19K
1-Year Change
-12.2%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4928 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
4,530.0
Downside
-4.43%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 13 consecutive years

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Noevir Holdings Co Ltd Company Profile

Noevir Holdings Co., Ltd. develops, produces, and sells cosmetics, pharmaceuticals, and health food products in Japan, China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, and Canada. The company’s Cosmetics segment develops, produces, and sells skincare products under various brands, including Noevir and Nameraka Honpo; excel make up line products and NOV hypoallergenic cosmetics, as well as provides contract manufacturing services for cosmetics and quasi drugs. Its Pharmaceutical & Health Food segment produces and sells Nanten Nodo Ame cough drops; functional drinks, such as the Min Min Da Ha; and over-the-counter pharmaceuticals comprising cold remedies, eye drops, and digestive aids, as well as nutritional supplements, and other products. The company’s Other segment sells and leases apparel and aircrafts. The company also produces and sells toiletries; market research; and provides air transportation and training services. The company sells its products through drug stores and variety stores, and dermatology and medical institutions, as well as Noevir beauty studios and own retail stores. Noevir Holdings Co., Ltd. was founded in 1964 and is headquartered in Kobe, Japan.

Compare 4928 to Peers and Sector

Metrics to compare
4928
Peers
Sector
Relationship
P/E Ratio
21.3x27.3x12.2x
PEG Ratio
11.76−0.200.03
Price/Book
3.2x1.7x1.5x
Price / LTM Sales
2.6x1.3x0.9x
Upside (Analyst Target)
−4.3%0.8%17.5%
Fair Value Upside
Unlock20.3%10.9%Unlock

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 4,530.0
(-4.43% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 222.59%
Dividend Yield
4.75%
Industry Median 2.75%
Annualised payout
225.00
Paid unevenly
5-Years Growth
+2.38%
Growth Streak

Earnings

Latest Release
Aug 05, 2025
EPS / Forecast
43.39 / --
Revenue / Forecast
15.25B / --
EPS Revisions
Last 90 days

4928 Income Statement

FAQ

What Stock Exchange Does Noevir Holdings Trade On?

Noevir Holdings is listed and trades on the Tokyo Stock Exchange stock exchange.

What Is the Stock Symbol for Noevir Holdings?

The stock symbol for Noevir Holdings is "4928."

What Is the Noevir Holdings Market Cap?

As of today, Noevir Holdings market cap is 161.90B.

What Is Noevir Holdings's Earnings Per Share (TTM)?

The Noevir Holdings EPS (TTM) is 222.59.

When Is the Next Noevir Holdings Earnings Date?

Noevir Holdings will release its next earnings report on 04 Aug 2025.

From a Technical Analysis Perspective, Is 4928 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Noevir Holdings Stock Split?

Noevir Holdings has split 0 times.

How Many Employees Does Noevir Holdings Have?

Noevir Holdings has 1369 employees.

What is the current trading status of Noevir Holdings (4928)?

As of 07 Aug 2025, Noevir Holdings (4928) is trading at a price of 4,740.00, with a previous close of 4,735.00. The stock has fluctuated within a day range of 4,705.00 to 4,760.00, while its 52-week range spans from 3,885.00 to 5,730.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.